Treatment options for HIV, AIDS.
D000273:Adipose Tissue; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D003240:Connective Tissue Diseases / Q000188:drug therapy*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015224:Dideoxynucleosides; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D005145:Face; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D019344:Lactic Acid / Q000627:therapeutic use; D019259:Lamivudine / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D011091:Polyesters; D011108:Polymers / Q000627:therapeutic use; D000099227:Abacavir
D019380:Anti-HIV Agents; D003841:Deoxycytidine; D015224:Dideoxynucleosides; D004338:Drug Combinations; D000069480:Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; D019344:Lactic Acid; D019259:Lamivudine; D009943:Organophosphorus Compounds; D011091:Polyesters; D011108:Polymers; C492871:abacavir, lamivudine drug combination; D000099227:Abacavir; C033616:poly(lactide)